Statements (18)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:acquiredBy |
gptkb:Bristol_Myers_Squibb
|
gptkbp:acquisitionYear |
2017
|
gptkbp:focusesOn |
immunology
immunotherapy inflammatory diseases |
gptkbp:foundedIn |
2015
|
gptkbp:founder |
gptkb:Gary_D._Glick
|
gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
IFM Therapeutics
|
gptkbp:industry |
gptkb:biotechnology
|
gptkbp:subsidiary |
gptkb:Bristol_Myers_Squibb
gptkb:IFM_Due gptkb:IFM_Quattro gptkb:IFM_Tre |
gptkbp:website |
https://www.ifmthera.com/
|
gptkbp:bfsParent |
gptkb:Bristol_Myers_Squibb
|
gptkbp:bfsLayer |
6
|